Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review
Christie Yao, Lori J. Bernstein, Jill B. Rich
Breast Cancer Research and Treatment (2017) Vol. 166, Iss. 1, pp. 15-28
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Prevalence of cognitive impairment and change in patients with breast cancer: A systematic review of longitudinal studies
Aicha B. C. Dijkshoorn, Haike E. van Stralen, Maurits Sloots, et al.
Psycho-Oncology (2021) Vol. 30, Iss. 5, pp. 635-648
Open Access | Times Cited: 108
Cognitive impairment in breast cancer survivors treated with chemotherapy depends on control group type and cognitive domains assessed: A multilevel meta-analysis
Lori J. Bernstein, Graham A. McCreath, Zahra Komeylian, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 83, pp. 417-428
Closed Access | Times Cited: 132
Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs
Jolie Ringash, Lori J. Bernstein, Gerald M. Devins, et al.
Seminars in Radiation Oncology (2017) Vol. 28, Iss. 1, pp. 64-74
Closed Access | Times Cited: 131
Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study
Yin Ting Cheung, Tara M. Brinkman, Chenghong Li, et al.
JNCI Journal of the National Cancer Institute (2017) Vol. 110, Iss. 4, pp. 411-419
Open Access | Times Cited: 78
Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and Neuroplasticity
Dongdong Shi, Yuhua Huang, Cora Sau Wan Lai, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5626-5642
Closed Access | Times Cited: 70
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.
Armando M. Marrufo, Stephen O. Mathew, Pankaj Chaudhary, et al.
PubMed (2018) Vol. 8, Iss. 6, pp. 1050-1063
Closed Access | Times Cited: 47
Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors
Diane Von Ah, Adele Crouch, Patrick O. Monahan, et al.
Journal of Cancer Survivorship (2021) Vol. 16, Iss. 4, pp. 812-822
Open Access | Times Cited: 27
Contemporaneous changes in cytokines and cognitive function during chemotherapy in patients with breast cancer: a prospective follow-up study
Shu‐I Wu, Vincent Chin-Hung Chen, Yen‐Hsuan Hsu, et al.
Breast Cancer (2025)
Open Access
Meta-analyses of executive function deficits in chemotherapy-treated rodent models
Weiye Chen, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2025), pp. 106131-106131
Open Access
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
Chemo-brain: An activation likelihood estimation meta-analysis of functional magnetic resonance imaging studies
Lori J. Bernstein, Kim Edelstein, Alisha Sharma, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 130, pp. 314-325
Closed Access | Times Cited: 24
Chemotherapy-Related Cognitive Impairment in Patients with Breast Cancer Based on Functional Assessment and NIRS Analysis
Noelia Durán-Gómez, Casimiro Fermín López-Jurado, Marta Nadal-Delgado, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2363-2363
Open Access | Times Cited: 17
Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results
Noemí Cerulla, Àngels Arcusa, J. Blas Navarro, et al.
Journal of Clinical and Experimental Neuropsychology (2018) Vol. 41, Iss. 3, pp. 290-299
Closed Access | Times Cited: 30
5-Fluorouracil impairs attention and dopamine release in rats
David P. Jarmolowicz, Rachel C. Gehringer, Shea M. Lemley, et al.
Behavioural Brain Research (2019) Vol. 362, pp. 319-322
Open Access | Times Cited: 28
Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms
Yen‐Hsuan Hsu, Vincent Chin‐Hung Chen, Ching‐Chuan Hsieh, et al.
Breast Cancer (2020) Vol. 28, Iss. 1, pp. 236-245
Closed Access | Times Cited: 26
Elevated Oxidative Stress and DNA Damage in Cortical Neurons of Chemotherapy Patients
Matthew Torre, Adwitia Dey, Jared K. Woods, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 7, pp. 705-712
Open Access | Times Cited: 19
A brief psychoeducational intervention improves memory contentment in breast cancer survivors with cognitive concerns: results of a single-arm prospective study
Lori J. Bernstein, Graham A. McCreath, Joyce Nyhof‐Young, et al.
Supportive Care in Cancer (2018) Vol. 26, Iss. 8, pp. 2851-2859
Closed Access | Times Cited: 23
Psychostimulants for cancer-related cognitive impairment in adult cancer survivors: a systematic review and meta-analysis
Nadia Miladi, Richi Dossa, Maman Joyce Dogba, et al.
Supportive Care in Cancer (2019) Vol. 27, Iss. 10, pp. 3717-3727
Closed Access | Times Cited: 22
Preliminary study on the effects of treatment for breast cancer: immunological markers as they relate to quality of life and neuropsychological performance
Michael J. Boivin, Geoffrey Aaron, Nathan G. Felt, et al.
BMC Women s Health (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 18
Pretreatment neurocognitive function and self‐reported symptoms in patients with newly diagnosed head and neck cancer compared with noncancer cohort
Lori J. Bernstein, Gregory R. Pond, Hui Gan, et al.
Head & Neck (2018) Vol. 40, Iss. 9, pp. 2029-2042
Closed Access | Times Cited: 19
Presence and predictors of anxiety disorder onset following cancer diagnosis among anxious cancer survivors
Joanna J. Arch, Sarah R. Genung, Michelle Ferris, et al.
Supportive Care in Cancer (2020) Vol. 28, Iss. 9, pp. 4425-4433
Open Access | Times Cited: 17
Distinct attentional function profiles in older adults receiving cancer chemotherapy
Inger Utne, Borghild Løyland, Ellen Karine Grov, et al.
European Journal of Oncology Nursing (2018) Vol. 36, pp. 32-39
Open Access | Times Cited: 17
Effects of Cancer, Chemotherapy, and Cytokines on Subjective and Objective Cognitive Functioning Among Patients with Breast Cancer
Vincent Chin‐Hung Chen, Chin‐Kuo Lin, Han‐Pin Hsiao, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2576-2576
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top